# North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding – FDA Inspection, Sep 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/c27b65d6-4ba0-4c25-8c22-7de5cfd3de16
Source feed: FDA_Inspections

> FDA inspection 1280796 of North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding, September 05, 2025. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 110. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1280796
- Company Name: North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
- Inspection Date: 2025-09-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1164181 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/06a65fad-a980-4edf-ba27-27c5b321af49)

## Related Officers

- [Investigator](https://www.keypedia.com/people/demario-l-walls/c69c4c87-f001-45ab-8d7b-b45c60226ff1)

Company: https://www.keypedia.com/companies/north-american-custom-laboratories-llc-dba-farmakeio-superior-custom-compounding/7c4b92d9-254c-4973-a722-4afe9513f3d6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
